P.07.15 INFLIXIMAB TROUGH LEVELS AND ANTI-DRUG ANTIBODIES AFTER INDUCTION AS PREDICTIVE FACTORS OF LONG TERM CLINICAL REMISSION

Authors :: Giorgia Bodini
C. De Maria
Edoardo Savarino
V. Savarino
L. Del Nero
I. Baldissarro
Edoardo G. Giannini
Source :: Digestive and Liver Disease. 48:e163
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Drug
medicine.medical_specialty
Hepatology
biology
business.industry
media_common.quotation_subject
Gastroenterology
Trough (economics)
Infliximab
Internal medicine
medicine
biology.protein
Antibody
business
media_common
medicine.drug

Tools